DIA
Drug Information Association Logo

DIA Conference Explores the Status of Clinical Trial Registries Worldwide

Basel, Switzerland — May 03, 2011

DIA in Europe will host the Clinical Trial Registries Conference from May 23-24 in Basel, Switzerland.

This two-day conference will discuss the status of clinical trial registries worldwide and provide insight from the authorities that operate them. Participants will also hear case studies of real-life implementations from industry and academic institutions. Sessions include:

  • Clinical Trial Registries - Overview of Current Situation Worldwide: EU, US and WHO
  • Overview of National, Company and Emerging Registries
  • What Purpose Do Registries Serve? How Do We Measure Their Success?
  • Implementation of Registries in Practice and Technical Implementation
  • Impact of the Clinical Trial Disclosure on the Planning and Conduct of Clinical Trials
  • Publication of Results
  • What Is Beyond Clinical Trials Transparency?

A decade after the launch of the ClinicalTrials.gov database and, more recently, the EU Clinical Trials Register, an increasing number of questions have arisen, including:

  • How can sponsors ensure the consistency and traceability of all the information submitted to these various repositories?
  • How do they organise their processes to deliver the required information in time with limited resources?

“Many still question the purpose of multiple registries and even argue that the original purpose of facilitating patients' access to clinical trials has not been met, while other suggest that industry and investors use the databases as competitive intelligence tools,” says Programme Chair Pierre-Yves Lastic,
Senior Director, Data Privacy & Healthcare Interoperability Standards, sanofi-aventis, France. “This conference will convene a distinguished panel of speakers from academia, patients organisations and the pharmaceutical industry to explore the validity of these issues.”

 

 

 

###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.